INTRODUCTIONCentral Centrifugal Cicatricial Alopecia (CCCA) is an irreversible primary scarring alopecia impacting up to 5.6% of Black women with significant diagnostic and therapeutic challenges.1 This study aims to review the…
Read More
INTRODUCTIONMinoxidil is a vasodilator used at higher doses as an anti-hypertensive, while low doses of oral minoxidil (LDOM) (between 0.25 and 5 mg) are effective in treating alopecia disorders. Rosacea…
Read More
INTRODUCTIONAtopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease that imposes a substantial burden through persistent itch, sleep disturbance, and impaired quality of life. Despite major advances in systemic…
Read More
Dear Editor,This report highlights that intralesional corticosteroids may serve as adjunctive therapy in alopecia areata patients who were initially steroid non-responders after a period of treatment with Janus kinase inhibitors…
Read More
INTRODUCTIONAlopecia areata (AA) is an autoimmune condition which affects roughly 2% of the population globally and is characterized by non-scarring hair loss.1 AA presents as patchy hair loss on the…
Read More
INTRODUCTIONMale androgenetic alopecia (AGA) and female pattern hair loss (FPHL) are common nonscarring hair loss disorders characterized by progressive scalp thinning, affecting up to 50% of men and women.1 In…
Read More
INTRODUCTIONDriven by the influence of social media, widespread availability of at-home nail kits, and easily accessible tutorials, the popularity of gel and acrylic nail polishes has surged making these stylish…
Read More
INTRODUCTIONAndrogenetic alopecia (AGA) is the most prevalent form of hair loss worldwide, affecting both men and women, with an estimated prevalence of up to 80% in males and approximately 40%…
Read More
INTRODUCTIONChronic hand eczema (CHE) is a common, heterogeneous inflammatory condition affecting the hands and wrists. Etiologic and morphologic patterns, such as irritant, allergic, atopic, hyperkeratotic, vesicular, and mixed presentations, are…
Read More
INTRODUCTIONPlaque psoriasis is a chronic immune-mediated disease driven by proinflammatory cytokines, such as interleukin (IL)-17, IL-12, IL-23, and/or tumor necrosis factor-alpha (TNF-alpha).1,2 The joint American Academy of Dermatology and National…
Read More
INTRODUCTIONFibroblast growth factor receptor inhibitors (FGFRi) are a novel class of targeted therapies used in the treatment of FGFR-mutant malignancies. Aberrant FGFR signaling via gene amplification, overexpression, activating mutations, or…
Read More
